Document is current
Any future updates will be listed below
-
Authors
Pineda-Moncusí, Marta
Servitja, Sonia
Tusquets, Ignasi
Diez-Perez, Adolfo
Rial, Albora
Cos, Maria Lourdes
Campodarve, Isabel
Rodriguez-Morera, Jaime
Garcia-Giralt, Natalia https://orcid.org/0000-0001-6507-0147
Nogués, Xavier
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03811509 at ClinicalTrials.govDocuments that mention this clinical trial
Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study
https://doi.org/10.1007/s10549-019-05289-7
-
Funding
Funding for this research was provided by:
CIBERFES (CB16/10/00245, CB16/10/00245)
Instituto de Salud Carlos III (PI16/00818, PI17/01875)
FEDER
- License Information
-
More Information
Article History
Received: 10 May 2019
Accepted: 18 May 2019
First Online: 24 May 2019
Compliance with ethical standards
:
: All authors declare that they have no conflict of interest.
: The ethics committee of Parc de Salut Mar (2016/6803/I) approved the study protocol, which was carried out in accordance with the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was obtained from all individual participants included in the study after they had read the study information sheet and any questions had been answered. The privacy rights of human subjects are carefully protected in our institution.
